Hospital-acquired infection Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

Friday, November 3, 2017 Hospital News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 2, 2017 /PRNewswire/ -- Hospital-acquired infection Diagnostics Market by Product (Instrument and Reagents and

Consumables) by Test Type (Molecular Diagnostics, Urinalysis, and Immunoassay) by Application (Disease Testing and Drug-Resistance Testing), by Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal
Infections, Urinary Tract Infections (UTI), and Others) and by End User (Hospital, Clinics, Ambulatory Surgery Centres (ASC) and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Download the full report:

Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others. Based on end user this market is segmented into hospital, clinics, ambulatory surgery centres (ASC) and others. By region, the market is analysed across North America, Europe, Asia-Pacific, and LAMEA.KEY BENEFITS FOR STAKEHOLDERSThe study provides an in-depth analysis of the global hospital-acquired infections market, with current trends and future estimations to elucidate the imminent investment pockets.Comprehensive analysis of factors that drive and restrict the market growth is provided.Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.Key market players and their strategies are provided to understand the competitive outlook of the market.KEY MARKET SEGMENTSBy ProductInstrument and ReagentsConsumablesBy Test TypeMolecular DiagnosticsUrinalysisImmunoassayBy ApplicationDisease Testing andDrug-Resistance TestingBy Infection TypeHospital Acquired PneumoniaBloodstream InfectionsSurgical Site InfectionsGastrointestinal InfectionsUrinary Tract Infections (UTI)OthersEnd UserHospitalClinicsAmbulatory Surgery Centers (ASC)OthersBY REGIONNorth AmericaU.S.CanadaMexicoEuropeUKFranceGermanyItalyRest of EuropeAsia-PacificJapanChinaIndiaAustraliaRest of Asia-PacificLAMEABrazilArgentinaTurkeySouth AfricaRest of LAMEAKEY PLAYERS PROFILEDAbbott LaboratoriesAdvanDXAlere Inc.AstraZeneca plcBayer Schering Pharma LLCBecton Dickinson & CompanyCepheid Inc.Roche AGDaiichi SankyoHologic, Inc.The other players in the value chain include (profiles not included in the report)GlaxoSmithKline plcJohnson & JohnsonMerck & Co.MeridienPfizerSeegeneDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store